Benefit-Risk Assessment of Obesity Drugs: Focus on Glucagon-like Peptide-1 Receptor Agonists. [electronic resource]

By: Contributor(s): Producer: 20200303Description: 957-971 p. digitalISSN:
  • 1179-1942
Subject(s): Online resources: In: Drug safety vol. 42
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review

There are no comments on this title.

to post a comment.